Litigation Details for ACTELION PHARMACEUTICALS LTD. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2019)
✉ Email this page to a colleague
ACTELION PHARMACEUTICALS LTD. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-12-31 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-07-10 |
| Cause | 15:1126 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 8,309,126 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ACTELION PHARMACEUTICALS LTD. v. ZYDUS PHARMACEUTICALS (USA), INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for ACTELION PHARMACEUTICALS LTD. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-12-30 | 1 | Complaint | prior to the expiration of U.S. Patent No. 8,309,126 (the “’126 patent”). … This is a civil action for patent infringement arising under the patent laws of the United States, … THE PATENT-IN-SUIT 11. The ’126 patent, entitled “Dispersible Bosentan…copy of the ’126 patent is attached hereto as Exhibit A. 12. The ’126 patent claims dispersible…the ’126 patent is listed in the Orange Book in connection with NDA No. 209279 as a patent “with respect | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
